Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Biotech
  • Contracts
  • General
  • Government
  • Health Care
  • Large Cap
  • News
  • Top Stories

Pfizer, European Pharma Firms Collaborate With European Commission For Future Health Emergency Preparedness

By Vandana Singh
June 30, 2:06 PM
The European Commission has reportedly made arrangements with Pfizer Inc (NYSE: PFE) and various European pharmaceutical companies to secure the capacity to produce up to 325 million vaccines annually for potential future global health crises.

BNTX

Read More
2 minute read
  • ETFs
  • Large Cap
  • News

Friday’s ETF Winners And Losers: Large-Cap Returns – XLE Gains 3.5% On The Week

By Johnny Rice
June 30, 1:52 PM
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest positive and negative returns on the week, according to data from etfdb.com. Only non-leveraged funds were considered. 

CVX

Read More
3 minute read
  • ETFs
  • Large Cap
  • News

Friday’s ETF Winners And Losers: Large-Cap Fund Flows – VOO and SPY Add More Than $1.5 Billion Each

By Johnny Rice
June 30, 1:51 PM
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest change in net assets on the week, according to data from etfdb.com. Only non-leveraged funds were considered.  Winners Vanguard S&P 500 ETF (NYSEARCA: VOO)

AAPL

Read More
2 minute read
  • General
  • Global
  • Large Cap
  • Markets
  • Mid Cap
  • News
  • Tech
  • Trading Ideas

Xpeng’s SUV Pricing Gambit Rattles Tesla Ahead Of Key Q2 Deliveries

By AJ Fabino
June 30, 12:42 PM
As the weekend approaches, investors hold their breath for Tesla Inc’s (NASDAQ:TSLA) April to June EV delivery report.…

BRK-A

Read More
2 minute read
  • Dividends
  • Earnings
  • General
  • Large Cap
  • Long Ideas
  • Markets
  • News
  • Trading Ideas

They’re After My Lucky Dividends: How to Earn $500 A Month from General Mills Stock

By AJ Fabino
June 30, 11:37 AM
Jerome Powell’s Federal Reserve increasing the interest rates isn’t just affecting the markets — they’re reaching into our…

GIS

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • M&A
  • Movers
  • News

Bausch + Lomb Poised To Boost Presence In Growing Market With Potential $1.75B Drug Acquisition Deal From Novartis

By Vandana Singh
June 30, 8:40 AM
Bausch + Lomb Corporation (NYSE: BLCO) has agreed to acquire 'front of eye' ophthalmology assets for $1.75 billion in upfront cash, plus additional milestone payments from Novartis AG (NYSE:

ABBV

Read More
2 minute read
  • Asia
  • Economics
  • Government
  • Large Cap
  • Regulations
  • Tech

Nvidia Shares Drop On Worries Over China Export Ban: Why Are Analysts Still Bullish?

By Piero Cingari
June 29, 4:10 PM
Shares of NVIDIA Corp. (NASDAQ:NVDA) fell more than 1% on Thursday, as investors sought clarity over the potential…

NVDA

Read More
2 minute read
  • Education
  • General
  • Large Cap
  • Legal
  • News
  • Topics

Supreme Court Ruling Casts Shadow On The Future Of College — And Corporate — Diversity

By AJ Fabino
June 29, 2:40 PM
In a decision that could reshape the landscape of higher education and consequently, corporate America, the U.S. Supreme…

AAPL

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer

By Vandana Singh
June 29, 1:39 PM
AstraZeneca Plc (NASDAQ: AZN) released updated results from the HIMALAYA Phase 3 trial evaluating Imfinzi (durvalumab) plus Imjudo (tremelimumab-actl) in unresectable hepatocellular carcinoma (HCC) patients who had not received prior systemic therapy and were not 

AZN

Read More
2 minute read
  • Analyst Color
  • Dividends
  • Emerging Market ETFs
  • ETFs
  • General
  • Global
  • Large Cap
  • Long Ideas
  • Markets
  • Mid Cap
  • News
  • Sector ETFs
  • Specialty ETFs
  • Trading Ideas

Amgen Out, Rio Tinto In As Morgan Stanley Shuffles Dividend Deck

By AJ Fabino
June 29, 1:03 PM
Industry giant Morgan Stanley (NYSE:MS) is shaking up its model for income-focused investors, indicating a strategic move towards…

AMGN

Posts pagination

Previous 1 … 278 279 280 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service